[
  {
    "Company": "Nilogen Oncosystems",
    "Model": "3D Patient Tumoroid with Intact TME",
    "Organs/Tissues": "Various solid tumors (e.g. lung, colorectal, melanoma, breast, etc.)",
    "Physiological/Pathological": "Pathological (human tumor tissue) with preserved immune/stromal context",
    "Cell Source": "Fresh patient tumor specimens → micro-fragments (tumor + stroma + immune cells)",
    "Multiple Cell Types": "Yes (tumor cells, fibroblasts, endothelial, immune infiltrates)",
    "Stromal Cells": "Yes, cancer-associated fibroblasts, etc., from the original tumor",
    "Tissue-resident Immune": "Yes, tumor-infiltrating lymphocytes, macrophages, etc.",
    "Circulating Immune": "No intrinsic circulation, but immune cells can be added externally (e.g. PBMCs, CAR-T)",
    "Crosstalk (Multi-tissue)": "No (single tumor model)",
    "Air-Liquid Interface": "No (submerged 3D fragments in medium)",
    "Extracellular Matrix": "Yes (native tumor ECM within each fragment)",
    "3D Scaffold": "Yes (tumor micro-fragment architecture)",
    "Notable Features": "Preserves patient-specific TME, short-term ex vivo culture, high-content imaging, immune/tumor interactions",
    "Plate/Format (Throughput)": "Standard multiwell plates (96-well), moderate/high throughput",
    "Max Culture Duration": "~3–5 days typical (up to ~1 week) for drug assays",
    "Readouts - Live Imaging": "Yes (confocal/fluorescence on 3D fragments)",
    "Readouts - Supernatant Sampling": "Yes (cytokines, etc.)",
    "Readouts - Cell Retrieval": "Yes (enzymatic dissociation post-treatment)",
    "Readouts - Whole Tissue": "Yes (fix tumoroids for IHC, immunofluorescence)",
    "Readouts - TEER": "No",
    "Readouts - MEA": "No",
    "Readouts - Integrated Biosensors": "No, external confocal/flow cytometry used",
    "Dead Volume": "Minimal (static well culture)",
    "Perfused": "No",
    "Gas Mix Controlled": "Standard incubator (5% CO2)",
    "Real-time Microenvironment Control": "Manual dosing, no dynamic flow",
    "model_availability": "Service only (CRO model using in-house tumoroids)"
  }
]
